04/17/2024
6:36 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
5:50 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:58 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:32 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:40 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:09 PM | Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:14 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/04/2024
6:18 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:22 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:56 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:00 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:05 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:39 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:44 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:50 PM | Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:53 PM | Abbott Laboratories (Subject)
Salvadori Daniel Gesua Sive (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:39 PM | Abbott Laboratories (Subject)
Moreland Mary K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:45 PM | Abbott Laboratories (Subject)
Morrone Louis H. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:22 PM | Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:25 PM | Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:32 PM | Abbott Laboratories (Subject)
MCCOY JOHN A. JR. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:13 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:45 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:35 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:38 PM | Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:40 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:43 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:27 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:29 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:33 PM | Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:23 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:03 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:15 PM | Abbott Laboratories (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/31/2024
4:30 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:04 PM | Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
6:36 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:38 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:28 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:30 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:33 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
4:36 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
10/18/2023
6:37 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
5:45 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:46 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:48 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:49 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
4:35 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
5:48 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2023
5:50 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
5:53 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:13 PM | Abbott Laboratories (Filer)
| Form 8-K/A | |
08/10/2023
5:31 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:10 PM | Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
7:29 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
10:54 AM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:55 AM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:56 AM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:57 AM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:57 AM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:07 PM | Abbott Laboratories (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/20/2023
5:55 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
2:18 PM | Abbott Laboratories (Subject)
Boudreau Philip P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
9:32 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
6:09 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
5:13 AM | Abbott Laboratories (Filer)
| Form S-3ASR | |
05/02/2023
6:57 PM | Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:59 PM | Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:02 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:04 PM | Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:08 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:51 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:53 PM | Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:55 PM | Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:33 PM | Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2023
6:34 PM | Abbott Laboratories (Subject)
MANNING JOSEPH J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
6:37 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:39 PM | Abbott Laboratories (Issuer)
Babineaux-Fontenot Claire (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:42 PM | Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:01 PM | Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
6:26 PM | Abbott Laboratories (Subject)
WOODGRIFT RANDEL WILLIAM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
2:25 PM | Abbott Laboratories (Subject)
STARKS DANIEL J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
5:00 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
